Erlotinib and gefitinib for the treatment of myelodysplastic syndrome and acute myeloid leukemia: A preclinical comparison-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Erlotinib and gefitinib for the treatment of myelodysplastic syndrome and acute myeloid leukemia: A preclinical comparison

Published:2008-12 Issue:11 Volume:76 Page:1417-1425
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Boehrer Simone,Adès Lionel,Galluzzi Lorenzo,Tajeddine Nicolas,Tailler Maximilien,Gardin Claude,de Botton Stéphane,Fenaux Pierre,Kroemer Guido

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference26 articles.

1. Proposals for the classification of the myelodysplastic syndromes;Bennett;Br J Haematol,1982

2. The World Health Organization (WHO) classification of the myeloid neoplasms;Vardiman;Blood,2002

3. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

4. Excessive apoptosis in low risk myelodysplastic syndromes (MDS);Parker;Leuk Lymphoma,2000

5. The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS;Parker;Blood,2000

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TGF-β-Based Therapies for Treating Ocular Surface Disorders;Cells;2024-06-26

2. The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells;Frontiers in Oncology;2021-09-28

3. Cell signaling pathways as molecular targets to eliminate AML stem cells;Critical Reviews in Oncology/Hematology;2021-04

4. Is the EGFR pathway relevant for the pathogenesis but not for treatment of acute myeloid leukemia?;Journal of Cancer Metastasis and Treatment;2021

5. Vibsanin A sensitizes human acute myeloid leukemia cells to tyrosine kinase inhibitor-induced myeloid differentiation via activation of PKC and upregulation of Lyn;Biochemical and Biophysical Research Communications;2018-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3